Kyverna Therapeutics

Kyverna Therapeutics

Est. revenue
$10M–$20M
Total raised
$295M
Latest round
Post-IPO Equity
Employees
177

Funding & revenue at Kyverna Therapeutics

How well capitalized the business is — useful context before you scope a fractional engagement or negotiate a rate.

Estimated annual revenue

$10M–$20M

Modeled range, not company-reported

Total capital raised

$295M

18 known investors

Latest round

Post-IPO Equity · $100M

Dec 2025

Publicly traded

KYVERNATHERAPEUTICS, KYTX

IPO Feb 2024

Investors

Argentum Capital For GrowthBain Capital Life SciencesCAM CapitalGilead SciencesGordonMD Global InvestmentsHealthCorHealthcor ManagementHudson Bay Capital ManagementInsight PartnersIntellia TherapeuticsLYFE CapitalNorthpond VenturesOxford Finance LLCRTW InvestmentsThe Argentum GroupVida VenturesWestlake Village BioPartnersjVen Capital

Growth signals

How fast Kyverna Therapeutics is adding people, roles, and audience.

Employees

177

Reported band 51-200

LinkedIn followers

47.9K

+94% year over year

Headcount change

MoM
+5.4%
+9 people
QoQ
+7.9%
+13 people
6mo
+14.2%
+22 people
YoY
+20.4%
+30 people
2yr
+30.1%
+41 people

Team composition

Where Kyverna Therapeutics concentrates its people — a read on which function a fractional leader would plug into.

By function

  • Research3520%
  • Business Development2313%
  • Operations1911%
  • Quality Assurance169%
  • Information Technology137%
  • Human Resources85%
  • Healthcare Services85%
  • Legal63%

By region

  • United States167
  • California, United States108
  • San Francisco Bay Area75
  • Los Angeles Metropolitan Area26
  • San Francisco, CA19
  • Emeryville, CA11

Inside Kyverna Therapeutics

What the business focuses on, where it operates, and how employees rate it.

Specialties

cell therapyautoimmunelupusmultiple sclerosissystemic sclerosissclerodermamyasthenia gravisCAR T-cellstiff-person syndrome

Categories

BiotechnologyLife ScienceTherapeuticsPharmaceutical and biotechnology

Markets

PRIVATENASDAQ

Competitors

Companies in the same market as Kyverna Therapeutics.

http://www.lycera.comhttps://www.revidarecovery.comhttp://www.alloteratx.comhttp://uvahealth.comhttp://www.neovacs.frhttp://www.cullgen.comhttp://www.CALVIRI.comhttp://www.abivax.comhttps://www.vyrobio.com/http://www.kymeratx.comhttps://kezarlifesciences.com/http://www.kyyouth.orghttp://deliniabio.comhttp://www.cartesiantherapeutics.comhttp://virdante.comhttp://kanyos.com

Kyverna Therapeutics in the news

Recent coverage picked up alongside the firmographic refresh.

Funding, revenue, headcount, and hiring figures are third-party estimates from public sources and are not confirmed by the company. Last refreshed October 16, 2026.

About this page

This company page is automatically generated based on publicly available job postings. Company information is sourced from publicly available data and may not be complete. If you represent Kyverna Therapeutics, you can claim this page to manage and enhance it.